PYRIDINYL AND PYRIMIDINYL SULFONAMIDE DERIVATIVES AS CHEMOKINE RECEPTOR MODULATORS
申请人:ALLERGAN, INC.
公开号:EP2970239A1
公开(公告)日:2016-01-20
SULFONAMIDE DERIVATIVES AS CHEMOKINE RECEPTOR MODULATORS
申请人:ALLERGAN, INC.
公开号:EP2970239B1
公开(公告)日:2018-10-10
US20140275132A1
申请人:——
公开号:US20140275132A1
公开(公告)日:2014-09-18
US9670190B2
申请人:——
公开号:US9670190B2
公开(公告)日:2017-06-06
[EN] PYRIDINYL AND PYRIMIDINYL SULFONAMIDE DERIVATIVES AS CHEMOKINE RECEPTOR MODULATORS<br/>[FR] DÉRIVÉS DE PYRIDINYL- ET PYRIMIDINYL-SULFONAMIDE EN TANT QUE MODULATEURS DE RÉCEPTEURS DE CHIMIOKINE.
申请人:ALLERGAN INC
公开号:WO2014159657A1
公开(公告)日:2014-10-02
The present invention relates to novel pyridine or pyrimidine derivatives of the Formula I, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals as modulators of chemokine receptors. The invention relates specifically to the use of these compounds and their pharmaceutical compositions to treat disorders associated with chemokine receptor modulation, such as ocular inflammatory diseases or skin inflammatory diseases.